Eurogin is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
You can submit your abstract for poster display or oral presentation through our online system. Don't miss the opportunity to present your research at an internationally renowned event.
All abstracts must be submitted through the online abstract submission system.
Late breaker deadline: on request – strict conditions to be complied with.
Submission of an abstract implies the commitment that the presenting author registers for the EUROGIN 2025 Congress and has adequate financial resources to attend.
For review purposes, abstracts are classified according to the following list. Select only 1 topic on our submission form.
1. HPV disease and COVID-19
2. Viral and molecular biology
3. Epidemiology and natural history
4. Pathogenesis
5. Immunology
6. HPV prophylactic vaccines
7. HPV therapeutic vaccines
8. Immunotherapy - Immuno-oncology - New treatments
9. HPV testing
10. HPV screening
11. Screening for women difficult to reach
12. Triage of HPV positive women
13. Self-sampling
14. Genotyping
15. Molecular markers
16. Screening methods
17. Methylation
18. Microbiome
19. Serology
20. New technologies
21. Artificial intelligence - Big data - Machine learning
22. Diagnostic procedures / management
23. Risk management
24. Colposcopy
25. Cervical neoplasia
26. Vulvar and vaginal diseases and neoplasia
27. Anal neoplasia
28. Oral HPV infection
29. HPV and oropharynx / Head and neck cancer
30. HPV and associated skin diseases
31. Genital warts
32. HPV transmission
33. Sexually transmitted diseases and HIV infection
34. Conventional therapies
35. Economics and modelling
36. Advocacy, acceptability and psychology
37. Health education
38. Low resource settings
39. Public health
40. Fertility and HPV